48 Stocks Moving In Monday's Mid-Day Session

Author: Lisa Levin | October 26, 2020 12:07pm

Gainers

• Muscle Maker, Inc. (NASDAQ:GRIL) shares jumped 50.7% to $2.3050. Muscle Maker, on Friday, reported the purchase of locations in Chelsea neighborhood of Manhattan.
• Lianluo Smart Limited (NASDAQ:LLIT) climbed 45.7% to $4.73 after the company and Newegg reported a merger agreement.
• Document Security Systems, Inc. (NYSE:DSS) shares climbed 35.7% to $5.48 after the company swung to a profit in the third quarter.
• Mid-Con Energy Partners, LP (NASDAQ:MCEP) climbed 24.5% to $2.5898 after the company merged with Contango Oil & Gas.
• RAVE Restaurant Group, Inc. (NASDAQ:RAVE) gained 18.4% to $0.8060. The company, earlier during October, announced it has hired Darren Webb as director of development for RAVE and Dion Firooznia as franchise business consultant for Pizza Inn.
• Selecta Biosciences, Inc. (NASDAQ:SELB) gained 17.1% to $3.3141. Last week, a Selecta Biosciences director indirectly added more than 5.31 million shares at $2.17 to $2.80 apiece.
• Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) jumped 17% to $0.1604 after the company announced a debt settlement agreement with two debt holders.
• Marin Software Incorporated (NASDAQ:MRIN) shares rose 16.2% to $4.00 after the company issued preliminary financial results for the third quarter. The company expects sales of $6.8 million and an adjusted loss of $2.7 million to $3 million.
• Westwater Resources, Inc. (NASDAQ:WWR) gained 16.2% to $4.63.
• Dunkin' Brands Group, Inc. (NASDAQ:DNKN) shares climbed 15.6% to $102.54. Dunkin Brands confirmed a New York Times report that the company has expressed an interest in selling itself. The New York Times reported that the company is in talks to sell itself to private equity-backed Inspire Brands.
• Galera Therapeutics, Inc. (NASDAQ:GRTX) gained 14% to $13.95 after the company's pilot phase trial for pancreatic cancer showed survival benefits.
• GeoVax Labs, Inc. (NASDAQ:GOVX) shares rose 13.9% to $3.4636 after the company announced a license agreement with the NIH to support coronavirus vaccine development.
• Mirati Therapeutics, Inc. (NASDAQ:MRTX) gained 13.6% to $204.73 following positive preliminary data for MRTX849 for patients with advanced non-small cell lung cancer.
• AnaptysBio, Inc. (NASDAQ:ANAB) climbed 11.2% to $28.60. AnaptysBio and GlaxoSmithKline amended strategic immuno-oncology collaboration.
• Co-Diagnostics, Inc. (NASDAQ:CODX) rose 10% to $13.71. Co-Diagnostics, earlier during the month, announced that its logic smart kit and will be used with the newly authorized Saline Oral rinse collection.
• Silvergate Capital Corporation (NYSE:SI) shares surged 9.7% to $22.70 following better-than-expected Q3 earnings.
• Global Cord Blood Corporation (NYSE:CO) climbed 9.2% to $4.1490.
• Smart Sand, Inc. (NASDAQ:SND) shares gained 8.8% to $1.3923. Smart Sand is estimated to release Q3 earnings on November 9.
• Fossil Group, Inc. (NASDAQ:FOSL) shares rose 8.4% to $6.59.
• Alliance Resource Partners, L.P. (NASDA: ARLP) gained 6.7% to $3.33 after the company reported better-than-expected Q3 earnings.

 

Check out these big penny stock gainers and losers

Losers

• BioSig Technologies Inc (NASDAQ:BSGM) shares dipped 40.2% to $3.0024 after the company disclosed that its ViralClear Pharmaceuticals subsidiary has halted its Phase 2 hospitalized COVID-19 trial.
• Aileron Therapeutics, Inc. (NASDAQ:ALRN) fell 29.5% to $1.34 after the company disclosed clinical data from ongoing ALRN-6924 Phase 1b trial.
• SAP SE (NYSE:SAP) dropped 22.9% to $115.46 after the company reported around 4% year-over-year drop in revenue for the third quarter and lowered its revenue outlook for the year.
• BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) shares declined 22.1% to $4.05 on continued momentum from Friday after the company announced the results from its pivotal, phase 3 clinical trial of M-001 as a standalone universal flu vaccine candidate did not meet both the primary and secondary efficacy endpoints.
• Revolution Medicines, Inc. (NASDAQ:RVMD) fell 18.6% to $32.88. Revolution Medicines reported progress and expansion of combination strategy with RMC-4630 as therapeutic backbone for RAS-addicted cancers and also disclosed collaboration with AstraZeneca. HC Wainwright & Co. maintained Revolution Medicines with a Buy and raised the price target from $52 to $54.
• CLPS Incorporation (NASDAQ:CLPS) fell 16.9% to $3.60. CLPS shares climbed around 12% on Friday after the company reported EPS and sales results up year-over-year for the second half of FY20.
• Nano Dimension Ltd. (NASDAQ:NNDM) shares declined 16% to $3.345 after the company priced its 16.722M ADS offering at $3 per share.
• TuanChe Limited (NASDAQ:TC) fell 15% to $3.81 after dropping over 25% on Friday.
• Bio-Path Holdings, Inc. (NASDAQ:BPTH) dropped 14.5% to $4.025. Bio-Path, last week, reported it got a notice of allowance for a strategic patent for prexigebersen in combo with front line cytidine analogues or Bcf-Abl tyrosine kinase inhibitors in a variety of cancers.
• Cenovus Energy Inc. (NYSE:CVE) dropped 14.7% to $3.1650 after the company announced a merger with Husky Energy under which Husky shareholders will receive 0.7845 Cenovus shares plus 0.0651 warrants per Husky shares owned.
• KBS Fashion Group Limited (NASDAQ:KBSF) shares declined 13.9% to $2.81 after declining over 16% on Friday.
• ProPhase Labs, Inc. (NASDAQ:PRPH) dipped 13.8% to $7.70. ProPhase Labs, on Friday, announced a definitive agreement to acquire a CLIA accredited laboratory certified for COVID-19 and upper respiratory testing for $2.5 million.
• 3D Systems Corporation (NYSE:DDD) fell 13.2% to $6.65 after William Blair reportedly issued commentary questioning the stock's recent rally.
• Mustang Bio, Inc. (NASDAQ:MBIO) fell 13.2% to $2.5611. Mustang Bio disclosed initial Phase 1 data on MB-105 for patients with PSCA-positive castration resistant prostate cancer.
• Integrated Media Technology Limited (NASDAQ:IMTE) dropped 12.5% to $4.20.
• MoneyGram International, Inc. (NASDAQ:MGI) fell 11.5% to $4.1850. MoneyGram recently reported a partnership with PayMaya Philippines to launch new digital capability to allow customers to send money from US to Philippines through Visa Direct.
• Leju Holdings Limited (NYSE:LEJU) fell 10.9% to $2.54 after gaining over 22% on Friday.
• Medigus Ltd. (NASDAQ:MDGS) fell 10% to $2.44. Medigus shares gained over 13% on Friday after its subsidiary ScoutCam announced the "success" of its micro ScoutCam 8.0 HD in NASA's Robotic Refueling Mission 3.
• Royal Caribbean Group (NYSE:RCL) dropped 10% to $58.04 amid an increase in new COVID-19 cases in the US and Europe.
• Hasbro, Inc. (NASDAQ:HAS) fell 9.8% to $83.00 despite reporting upbeat quarterly results.
• Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) fell 9.4% to $16.64 amid an increase in new COVID-19 cases in the US and Europe.
• Carnival Corporation & Plc (NYSE:CCL) dipped 9.1% to $13.97 amid spikes in new COVID-19 cases in the United States and Europe.
• Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) fell 9% to $12.70. Crinetics Pharmaceuticals announced its phase 2 ACROBAT study met its primary endpoint.
• Astrotech Corporation (NASDAQ:ASTC) shares fell 7.5% to $2.2299. Astrotech, last week, announced pricing of $18 million offering at $2.30 per share.
• Callon Petroleum Company (NYSE:CPE) fell 7.5% to $4.9013. Callon Petroleum, earlier during the month, announced $170 million in asset monetizations and issued $300 million in secured second lien notes.
• Ever-Glory International Group, Inc. (NASDAQ:EVK) fell 6.6% to $2.56 after gaining over 5% on Friday.
• Zedge, Inc. (NYSE:ZDGE) fell 6% to $2.39. Zedge shares jumped over 60% on Friday after the company reported better-than-expected Q4 results.
• Elbit Systems Ltd(NASDAQ:ESLT) fell 4.7% to $114.39 after the company said it expects a $60M asset write off due to reduced demand.

Posted In: ALRN ANAB ASTC BPTH BSGM BVXV CCL CLPS CO CODX CPE CRNX CVE DDD DNKN DSS ESLT EVK FOSL GOVX